Alkem Laboratories has acquired an undertaking, as a whole and on a going and running concern basis from Cachet Pharmaceuticals, a subsidiary of the Company. The Company was getting some of its liquid products like syrups, etc. manufactured from the said Undertaking and was procuring other liquid items from other parties as the Company did not have any undertaking to produce liquid pharmaceutical products.
Hence, it was proposed to acquire the said Undertaking with a view to manufacture most of its requirement of liquid products at one place for better control over the quality of the products and timely supplies of the products by the Company. The cost of acquisition is Rs 51.85 crore.
Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.